# LAMIVUDINE
> **ANDA206974** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2016-11-21
## Drug
- **FDA Application Number:** ANDA206974
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** LAMIVUDINE
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Ingenus Pharmaceuticals, LLC
- **First approval:** 2016-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206974)
---
*MORVS · CC0 1.0*